ReviewRadiologie (Heidelberg, Germany)2026
[Differential diagnoses of malignant bone marrow diseases].
Review in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBone marrow abnormalities are frequent radiological findings with a broad spectrum ranging from physiological conversion/reconversion to malignant infiltration.
objectiveThis article summarizes important differential diagnoses of malignant bone marrow lesions and presents a practical diagnostic approach. MATERIAL AND
methodsNarrative review based on the current literature, focusing on magnetic resonance imaging (MRI), computed tomography (CT) and supplementary techniques, such as chemical-shift imaging (CSI), Dixon sequences, diffusion-weighted imaging (DWI) and positron emission tomography CT (PET/CT).
resultsNon-fat-suppressed T1-weighted MRI is central for bone marrow assessment. A signal intensity lower than skeletal muscle or intervertebral discs argues against simple reconversion and should raise the suspicion of infiltration. The CSI and Dixon techniques help differentiate benign mimics by demonstrating intralesional fat. Important differential diagnoses include metastases, leukemia, lymphomas, myeloproliferative disorders, multiple myeloma, reconversion, bone infarcts, chronic nonbacterial osteitis (CNO)/chronic recurrent multifocal osteomyelitis (CRMO), Langerhans-cell histiocytosis (LCH), enostosis and osteomyelitis.
conclusionThe diagnosis requires integration of imaging patterns, fat content, mineralization, age, clinical context, tumor history and course. In unclear or aggressive findings, imaging follow-up or biopsy is required.
Indexed as
Identifiers
42440079What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.